<!DOCTYPE html>
<html lang="en">
<head id="Head1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <meta http-equiv="content-type" content="text/html;charset=utf-8" />
    <meta http-equiv="X-UA-Compatible" content="IE=Edge" />
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>Full Text of HR0158</title>
    <link rel="shortcut icon" type="image/x-icon" href="https://cdn.ilga.gov/assets/img/site/favicon.ico" />
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap.min.css" />
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.css" rel="stylesheet">
    <script src="https://cdn.ilga.gov/assets/js/fontawesome/fa.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/jquery.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/js.cookie.min.js"></script>
    <script async src="https://cse.google.com/cse.js?cx=a47f92b5e11c1499a"></script> 
    <!-- Bootstrap Datepicker CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/assets/css/bootstrap/bootstrap-4.6.2-dist/css/bootstrap-datepicker.min.css">
    <!-- Bootstrap Datepicker JavaScript -->
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap-datepicker.min.js"></script>
    <!-- aos, bootstrap icons, swiper CSS -->
    <link href="https://cdn.ilga.gov/assets/css/aos/aos.css" rel="stylesheet">
    <link href="https://cdn.ilga.gov/assets/css/swiper/swiper-bundle.min.css" rel="stylesheet">

    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/bootstrap-table.min.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/bootstrap-table/1.18.3/extensions/filter-control/bootstrap-table-filter-control.min.js"></script>

    <!-- ILGA main CSS -->
    <link rel="stylesheet" href="https://cdn.ilga.gov/main.css" />
    <link rel="stylesheet" type="text/css" media="print" href="https://cdn.ilga.gov/assets/css/print.css">
    <style></style>
    
</head>
<body>
        <!-- ======= Header ======= -->
        <header id="print-header" class="d-flex align-items-center">
            <div class="container-fluid align-items-center text-uppercase justify-content-start ">
                <div class="logo ">
                    <a href="/"><img src="https://cdn.ilga.gov/assets/img/site/white_capitol.png" alt="ILGA Logo"><span>ILGA.GOV</span></a>
                </div>
                <div class="w-100"></div>
            </div>
        </header>
    <input id="TextSearch" type="hidden" />
    <input id="MobileTextSearch" type="hidden" />
    <input id="message-input" type="hidden" />

    <main id="main-content" role="main">
        <section class="main-page p-2">
	<div class="p-1 pt-4 float-left">
		<div class="row border-bottom pb-3 mb-3">
			<div class="text-start">
				<h2>
					HR0158 - 104th General Assembly
				</h2><br />
			</div>
		</div>
		<div id="content">
			<!-- Full text only shows on large screens -->
			<div class="centered-container d-lg-flex">
				<div class="left-aligned-content">
					<div class="row">
						<div class="col pl-lg-5" translate="no">
							<text class="ml-5 text-left fulltextLineHeight" id="billtextanchor">
								<style>
								
								
								
								table.xsl	{ 	border-collapse: collapse;
												border: 0px solid black;
												font-family: "courier New"; 
												font-size: 10pt;}
								
								td.xsl		{ 	border-collapse: collapse;
												border: 0px solid black;
												padding-top: 3pt;
												padding-bottom: 3pt;
												padding-left: 0pt;
												padding-right: 0pt;
												font-family: "courier New"; 
												font-size: 10pt; }
												
								td.junk		{ 	width: 5%; }
								 
							
					
					
						body.xsl		{ 	text-align:center; }
						
					
						td.lineNum 		{ 	vertical-align: top; 
										  	text-align: right;
										  	font-family: "courier New"; 
										  	font-size: 10pt; }
							
						td.number 		{	width: 5%;
											vertical-align: top; 
										  	text-align: right;
										  	font-family: "Courier New", sans-serif;
										  	font-size: 10pt; }
						
						td.synopsis		{ 	border-collapse: collapse;
											border: 0px solid black;
											padding-top: 0pt;
											padding-bottom: 0pt;
											padding-left: 0pt;
											padding-right: 0pt;
											font-family: "courier New"; 
											font-size: 10pt; }
						
						td.rowsep		{ 	border-bottom: 1px solid black; }
											
						td.colsep		{ 	border-right: 1px solid black; }
											
						td.bothsep		{ 	border-right: 1px solid black;
										  	border-bottom: 1px solid black; }
	
						table.top		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black; }
											
						table.bottom	{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-bottom: 1px solid black; }
											
						table.sides		{ 	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black; }
	
						table.all		{ 	font-family: "Courier New", sans-serif;
										  	font-size: 10pt;
									  	  	border-left: 1px solid black;
									  	  	border-right: 1px solid black;
									  	  	border-bottom: 1px solid black;
									  	  	border-top: 1px solid black; }				
	
						table.topbot	{ 	border-collapse: separate;
									  	  	border: outset 0pt;
										  	font-family: "Courier New", sans-serif;
									  	  	font-size: 10pt;
									  	  	border-top: 1px solid black;
									  	  	border-bottom: 1px solid black; }
					
						.sigline		{ 	text-align: left;
							 		 		vertical-align: bottom;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.siglinetext		{ 	text-align: left;
							 		 		vertical-align: top;
							 				padding-top: 3pt;
							 				padding: 0pt; }
							 				
						.sigtitle		{ 	text-align: left;
							 				vertical-align: top;
							 				padding: 0pt; }
							 				  
						.sigtitlenum		{ 	text-align: right;
							 				vertical-align: top;
							 				padding: 0pt; }
							
						.siglinenum		{ 	text-align: right;
							 				vertical-align: center;
							 				padding-top: 3pt;
							 				padding: 0pt; }
					</style><table class="xsl" width="578"><pre><tr><td class="xsl" colspan="3"><p> </p><br> </td></tr></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HR0158</td><td class="xsl" align="center"></td><td class="xsl" align="right">LRB104 12436 ECR 22753 r</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><center><code>HOUSE RESOLUTION</code></center><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, The original intent of the 340B Drug Pricing </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>Program was to provide discounted medicines to eligible </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>healthcare organizations for the purpose of improving access </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>to affordable medications for low-income, underinsured, and </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>uninsured patients being treated at eligible hospitals, </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>including disproportionate share hospitals, clinics, federally </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>qualified health centers (FQHC), and safety-net hospitals; and</code><br> </td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, The 340B Program, established in 1992, was </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>designed to restore manufacturers' ability to offer discounts </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>to safety net entities, fixing an unintended problem created </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>by the Medicaid Drug Rebate Program (MDRP) enacted in 1990; </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>and</code><br> </td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Congress intended the 340B Program to provide </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>discounts only to federally-funded clinics and public </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>hospitals that provide direct clinical care to large numbers </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>of uninsured Americans; and</code><br> </td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, The lack of transparency and accountability of </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>the 340B Program has resulted in the expansion of services to </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>commercially insured patient populations who are charged full </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>price for drugs purchased at steeply discounted 340B prices, </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>resulting in the intended benefit to not reach the vulnerable </code></td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HR0158</td><td class="xsl" align="center">- 2 -</td><td class="xsl" align="right">LRB104 12436 ECR 22753 r</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>patient populations that the program was designed to help; and</code><br> </td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, As the 340B Program is not serving vulnerable </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>patients in the way that was intended, there is a need for </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>increased understanding regarding how covered entities utilize </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>the 340B Program and the eventual benefits that reach </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>low-income patients; and</code><br> </td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Nationally, the 340B Program reached $66.3 </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>billion in 2023, representing a 24% increase over the </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>preceding year; and</code><br> </td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, While 340B profits have increased, Illinois </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>hospitals only provide 2.14% of charity care compared to the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>national average of 2.28%; and</code><br> </td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, The appropriate and effective use of the 340B </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>Program is essential for improving health outcomes, </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>particularly for underserved communities in rural, suburban, </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>and urban areas throughout Illinois; and</code><br> </td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Pharmacy benefit managers (PBM) play a </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>significant role in the healthcare ecosystem, and their </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>practices regarding 340B revenue must be transparent and </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>accountable; and</code><br> </td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HR0158</td><td class="xsl" align="center">- 3 -</td><td class="xsl" align="right">LRB104 12436 ECR 22753 r</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Half of the 340B contract pharmacies intended to </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>serve underserved patients in Illinois are located in affluent </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>neighborhoods; and</code><br> </td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Of the top five Illinois hospitals with the most </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>contract pharmacies, 24% of their 340B contract pharmacies are </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>based outside of Illinois; and</code><br> </td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, The integrity and efficacy of state health </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>programs, such as Medicaid and the State Employees Group </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>Insurance Program, could be impacted by the lack of </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>transparency of the 340B Program and current practices; and</code><br> </td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, The North Carolina Treasurer's report on the 340B </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>Program found that individual 340B hospitals collected as much </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>as $6,026 in average profits per claim by charging up to 12.7 </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>times their 340B acquisition costs for oncology drugs when </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>treating North Carolina state employees with outpatient </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>oncology infusion drugs; and</code><br> </td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, That same report stated, based on its findings, </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>at the very least, policymakers should consider strengthening </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>public oversight of the 340B Program by introducing </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>transparency requirements and bolstering accountability for </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>the charitable mission of hospitals; and</code><br> </td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HR0158</td><td class="xsl" align="center">- 4 -</td><td class="xsl" align="right">LRB104 12436 ECR 22753 r</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, The report also stated, based on its findings, </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>ultimately, the 340B Program's systemic lack of accountability </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>has hurt those 340B hospitals and other safety-net providers </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>that operate in good faith to provide lifesaving care to </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>disadvantaged patients; and</code><br> </td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Ensuring the transparency and accountability of </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>the 340B Program is important to understanding the potential </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>long-term costs to taxpayers, including self-insured </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>employers, because of its impact on incentivizing increasing </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>provider consolidation, distorting incentives for efficient </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>care, and impacting overall utilization; and</code><br> </td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Increasing the transparency and accountability </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>within the 340B Program can foster better health outcomes for </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>our most vulnerable patients and ensure taxpayer funding is </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>utilized responsibly and effectively; and</code><br> </td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>    </code><code>WHEREAS, Improving the transparency and accountability </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>within the 340B Program will ensure those 340B hospitals </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>providing needed support to our most vulnerable patients will </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>continue to access discounted medicines, and that any benefit </code></td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>stays with vulnerable patient populations and not with large, </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>wealthy hospital systems and PBM contracted pharmacies; </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>therefore, be it</code><br> </td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HR0158</td><td class="xsl" align="center">- 5 -</td><td class="xsl" align="right">LRB104 12436 ECR 22753 r</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>RESOLVED, BY THE HOUSE OF REPRESENTATIVES OF THE ONE </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>HUNDRED FOURTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>we direct the Auditor General to conduct a comprehensive </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>investigation of the utilization of the 340B Drug Pricing </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>Program by covered entities within Illinois; and be it further</code><br> </td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>    </code><code>RESOLVED, That this investigation shall assess the amount </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>of 340B profit, defined as total patient and payer </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>reimbursement less the total 340B acquisition cost, generated </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>by 340B covered entities from both self-administered and </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>physician-administered drugs, the amount spent on third party </code></td></tr><tr><td class="number">11</td><td class="junk"></td><td class="xsl" ><code>administrators for the management of the 340B Program, the </code></td></tr><tr><td class="number">12</td><td class="junk"></td><td class="xsl" ><code>amount going to pharmacy benefit managers (PBM) in contract </code></td></tr><tr><td class="number">13</td><td class="junk"></td><td class="xsl" ><code>pharmacy arrangements, the amount going to contract </code></td></tr><tr><td class="number">14</td><td class="junk"></td><td class="xsl" ><code>pharmacies, whether covered entities maintain title to 340B </code></td></tr><tr><td class="number">15</td><td class="junk"></td><td class="xsl" ><code>drugs in contract pharmacy locations, the average mark-up </code></td></tr><tr><td class="number">16</td><td class="junk"></td><td class="xsl" ><code>imposed by covered entities on 340B priced drugs, and the </code></td></tr><tr><td class="number">17</td><td class="junk"></td><td class="xsl" ><code>extent to which 340B entities pass 340B discounts to </code></td></tr><tr><td class="number">18</td><td class="junk"></td><td class="xsl" ><code>vulnerable patients at the point of sale for both in-house and </code></td></tr><tr><td class="number">19</td><td class="junk"></td><td class="xsl" ><code>contracted pharmacies; and be it further</code><br> </td></tr><tr><td class="number">20</td><td class="junk"></td><td class="xsl" ><code>    </code><code>RESOLVED, That this investigation shall also examine the </code></td></tr><tr><td class="number">21</td><td class="junk"></td><td class="xsl" ><code>impact of these practices on state health programs, such as </code></td></tr><tr><td class="number">22</td><td class="junk"></td><td class="xsl" ><code>Medicaid and the State Employees Group Insurance Program, and </code></td></tr><tr><td class="number">23</td><td class="junk"></td><td class="xsl" ><code>to make recommendations for improvement; and be it further</code><br> </td></tr></table><table class="xsl" width="578"><tr><td class="lineNum" colspan="3"><p> </p><p> </p></td></tr><tr><td class="xsl" colspan="3"><table class="xsl" width="100%"><colgroup width="5%"></colgroup><colgroup width="5%"></colgroup><colgroup width="30%"></colgroup><colgroup width="20%"></colgroup><colgroup width="40%"></colgroup><tr><td class="number"></td><td class="junk"></td><td class="xsl" align="left">HR0158</td><td class="xsl" align="center">- 6 -</td><td class="xsl" align="right">LRB104 12436 ECR 22753 r</td></tr></table></td></tr><tr><td class="xsl"><br></td></tr><tr><td class="number">1</td><td class="junk"></td><td class="xsl" ><code>    </code><code>RESOLVED, That suitable copies of this resolution be </code></td></tr><tr><td class="number">2</td><td class="junk"></td><td class="xsl" ><code>delivered to the Illinois Auditor General Frank J. Mautino, </code></td></tr><tr><td class="number">3</td><td class="junk"></td><td class="xsl" ><code>Governor JB Pritzker, Secretary Dulce M. Quintero of the </code></td></tr><tr><td class="number">4</td><td class="junk"></td><td class="xsl" ><code>Illinois Department of Human Services, Director Kelly </code></td></tr><tr><td class="number">5</td><td class="junk"></td><td class="xsl" ><code>Cunningham of State Medicaid and CHIP, and the respective </code></td></tr><tr><td class="number">6</td><td class="junk"></td><td class="xsl" ><code>directors of each of the State Employees Group Health </code></td></tr><tr><td class="number">7</td><td class="junk"></td><td class="xsl" ><code>Insurance Program plans to emphasize the State's commitment to </code></td></tr><tr><td class="number">8</td><td class="junk"></td><td class="xsl" ><code>improving the transparency of the 340B Program and ensuring </code></td></tr><tr><td class="number">9</td><td class="junk"></td><td class="xsl" ><code>that it effectively and efficiently serves the healthcare </code></td></tr><tr><td class="number">10</td><td class="junk"></td><td class="xsl" ><code>needs of all Illinoisans.</code></pre></table>
							</text>
						</div>
					</div>
				</div>
			</div>
		</div>
    </div>
</section>
    </main>
    <!-- Vendor JS Files -->
    <script src="https://cdn.ilga.gov/assets/js/aos/aos.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/jquery/popper.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/bootstrap/bootstrap.bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/glightbox/glightbox.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/swiper/swiper-bundle.min.js"></script>
    <script src="https://cdn.ilga.gov/assets/js/main.js"></script>

    

</body>
</html>
